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Abstract
Background: Endometriosis is a common estrogen-dependent disease. The aim of this study was to assess
whether controlled ovarian hyperstimulation (COH) for assisted reproductive technology (ART) was associated
with an increased incidence in endometriosis recurrence as documented by transvaginal ultrasound (TV-US).
Methods: In a retrospective cohort study of 592 patients submitted to laparoscopy for endometriosis, 177 with
infertility-related endometriosis who underwent a periodic ultrasound follow-up after laparoscopy were se-
lected. Women who started ART after laparoscopy (n¼ 90) were compared with the control group, who did not
undergo ART (n¼ 87). Recurrence of endometriosis was defined as the presence of endometriotic lesions ob-
served through TV-US.
Results: During a long-term TV-US follow-up (1–15 years), 40 (22.6%) recurrences were observed. Patients
submitted to ART showed a cumulative recurrence rate similar to that of the control group (28.6% and 37.9%
respectively, p¼ 0.471). Recurrent lesions were ovarian cysts (47.5%), ovarian nodules (37.5%), and rectovaginal
disease (15%). The stratified analysis based on stages of endometriosis and pelvic pain did not show differences.
Conclusions: Gonadotropin treatments do not seem to affect the natural history of endometriotic lesions. The
most important prognostic factors in recurrent disease observed by TV-US seem to be the stage of endometriosis
and the presence of pelvic pain at the time of the first laparoscopic treatment.
Introduction
Endometriosis is a benign gynecological disease de-fined as the presence of endometrial glands and stroma
outside of the uterine cavity. It affects 5%–10% of women of
reproductive age and produces symptoms including dys-
menorrhea, deep dyspareunia, and chronic pelvic pain.1 The
demographics of this disorder support a close relationship
between endometriosis and ovarian hormone levels. Signs
and symptoms are rarely observed before menarche and
usually regress after menopause. Because conditions of es-
trogen excess have been reported to exacerbate endometriosis,
traditional medical treatments aim to decrease ovarian pro-
duction of estradiol (E2).
2 The recurrence rate in women who
undergo conservative surgery for endometriosis ranges from
2% to 51%.3,4 Some authors suggest that the risk of recurrence
tends to rise with further age and advanced stages of the
disease, whereas it lessens in women with infertility.3 These
data are still controversial, however.
Early studies showed that 30%–50% of women with en-
dometriosis are infertile.1 Frequently, infertile women with a
history of endometriosis are encouraged to undergo treat-
ment with assisted reproductive technology (ART) in order to
conceive. Some authors recommend that if the objective is
basically treating infertility, in vitro fertilization (IVF) without
first performing surgery is probably a good option.5 On the
other hand, controlled ovarian hyperstimulation (COH) for
ART produces a high level of E2 for short periods of time that
could induce the growth of endometriotic implants.
Although endometriosis is a recurrent disease and is es-
trogen dependent, there are surprisingly few data about
recurrence risks in patients with infertility-associated endo-
metriosis after COH. As a consequence of the wide diffusion
of ART in these women, there is a need to evaluate the risk of
causing the recurrence or worsening of endometriosis because
of human chorionic gonadotropin (HCG) treatment. Only a
few case reports have been published on this topic. These data
imply that COH may lead to a higher recurrence rate of
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endometriosis. One case report describes a patient experi-
encing acute renal colic after ovarian stimulation.6 In a second
case series, 4 patients showed rapid growth of sigmoid en-
dometriosis under COH for IVF.7
In a retrospective cohort study (including patients with
moderate-severe endometriosis and a history of multiple
endometriosis surgeries), the cumulative endometriosis re-
currence rate in 36 months of follow-up was similar in the
pre-ART group without COH and the post-ART group with
COH. Moreover, cumulative recurrence rates were lower af-
ter ovarian hyperstimulation for IVF than after lower-dose
ovarian stimulation for intrauterine insemination (IUI).8
The current study attempts to answer the question of
whether patients with a previous history of endometriosis,
when submitted to COH for ART, are exposed to a higher
recurrence risk compared with a control group of women
never submitted to COH.
Materials and Methods
Patient recruitment
A retrospective cohort study was conducted on 592 pa-
tients submitted to laparoscopy for endometriosis between
March 1993 and November 2007 in the Department of Gy-
naecology, Perinatology and Human Reproduction at the
University of Florence, Italy. Our eligibility criteria for this
study were the following: patients undergoing their first
laparoscopy for endometriosis, histologically confirmed di-
agnosis of endometriosis, infertility diagnosed either before
or after laparoscopy, and at least once a year periodic
clinical and transvaginal ultrasound (TV-US) follow-up after
surgery.
During follow-up evaluation, we studied the patient’s
clinical history, symptoms at the time of her first surgery, TV-
US findings, and reproductive outcome. Data were analyzed
and compared on the basis of ART treatments: patients de-
ciding to undergo ART after laparoscopy were considered the
study group, and the control group consisted of women not
submitting to ART. Women who chose to attempt ART after
surgery but were diagnosed with recurrent endometriosis
before ART cycles were included in the control group. Pos-
sible effects of ART treatment type (IUI or IVF) and number of
cycles attempted were also analyzed. We did not include in
the analysis the values of E2 on the day of hCG because pa-
tients included in the study had differing numbers and types
of cycles (IUI=IVF).
In a further analysis, we stratified the results considering
the stage of endometriosis and the presence of pain before
undergoing the first surgery. Endometriosis was staged ac-
cording to the revised American Society for Reproductive
Medicine criteria (r-ASRM).9 Presence of pain (dysmenorrhea,
dyspareunia, or chronic pelvic pain) before surgery was de-
fined on the basis of a visual analogue scale (VAS) measure-
ment superior to 5 cm. The institution does not claim board
approval for this retrospective study.
Laparoscopy
All our laparoscopies were performed by the same three
skilled surgeons under general anesthesia. A 10-mm laparo-
scope was inserted in the standard umbilical position, and
three 5-mm trocars were inserted suprapubically under direct
vision. During surgery, all visible endometriotic lesions were
excised. The stripping technique was used to remove ovarian
endometriomas. Tubo-ovarian adhesions were lysed using
sharp dissection to restore normal anatomy. The complete
excision of pelvic endometriotic lesions was carried out using
scissors and bipolar coagulation. Chromoperturbation with
methylene blue dye was performed in all patients.
Controlled ovarian stimulation
In patients choosing ART after the first surgery, a long-
acting downregulation drug regimen was used. Daily sub-
cutaneous administration of triptorelin (Decapeptyl 0.1mg,
IPSEN Italy) was started on day 21 of the previous cycle. After
downregulation (verified after adequate ovarian suppression
at pelvic US and circulating E2 values <35 pg=mL), we initi-
ated a daily subcutaneous administration of 150 IU (for IUI)
and 225–300 IU of follicle-stimulating hormone (FSH) (puri-
fied urinary FSH, Metrodin HP 75 IU, or recombinant FSH,
Gonal-F 600 IU, Serono, Italy). Serial US scans and E2 dosage
determinations were performed during ovarian stimulations.
When at least two follicles reached a maximum diameter of
17–18mm, 10,000 IU of hCG (Gonasi 5000 IU, two ampoules,
Amsa, Italy) was administered subcutaneously.
In women submitted to IUI, an intrauterine insemination
was done after 36 hours. In IVF patients, echo-guided trans-
vaginal oocyte retrieval was performed 35–36 hours later. All
oocytes retrieved were scored and inseminated for IVF (only
three oocytes after the assisted reproduction Law 40=2004),
and fertilization was assessed the following day. Two days
after oocyte pickup, amaximumof two to three embryoswere
transferred. The luteal phase was supported with a daily
administration of 50mg intramuscularly of natural proges-
terone in oil (Prontogest, Amsa, Italy) starting the day after
the oocyte retrieval. Pregnancy was assessed through plasma
b-hCG values 14 days after oocyte retrieval. At 6 weeks,
clinical pregnancies were confirmed through the presence of
an intrauterine gestational sac with a fetal pole and heart ac-
tivity observed by a TV-US examination.
Recurrence definition
Recurrence was defined as the presence of endometriotic
cysts or nodules observed during a TV-US. In particular, an
ovarian endometrioma was characterized by a persistent
circular homogeneous, hypoechoic tissue without papillary
proliferations and with a clear demarcation from the ovarian
parenchyma.10–15 Ovarian nodules were defined as lesions
<20mm in mean diameter. Deep endometriosis implants, in
particular rectosigmoid and rectovaginal septum involve-
ment, were suspected from the presence of hypoechoic
linear thickening or nodules=masses with or without regu-
lar contours that had thin bandlike echoes departing from
the center of the mass that were defined as Indian head-
dress.16,17
Recurrent endometriosis may develop from residual mi-
croscopic lesions left after the first surgery. On this basis, we
decided to consider as the time of entry into the study the date
of primary surgery for both control and study groups. If the
patient had received an additional treatment with gonado-
tropin-releasing hormone (GnRH) analogues immediately
after the surgery, the time of entry into the study was delayed
1 month after the last injection of GnRH analogues. The time
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in which patients left the studywas considered either the time
at which recurrence was diagnosed or the conclusive follow-
up visit date.
Statistical analysis
Statistical analyses were performed using a t test for para-
metric data or a chi-square test for categorical data. Because
life table analysis is amethod that allows the time of follow-up
to be taken into account, we estimated the differences in cu-
mulative recurrence rates of endometriosis between groups
according to the Kaplan-Meier method. Statistical differences
between the curves were calculated using the log-rank test. A
p value<0.05 was considered to be statistically significant. All
statistical analyses were performed using SPSS software,
version 13 (SPSS, Chicago, IL).
Results
Overall, 177 patients satisfied the criteria and were in-
cluded in the study. One hundred sixteen (65.5%) women
were submitted to ovarian cystectomy for ovarian en-
dometriomas, 80monolateral and 36 bilateral (mean diameter
35.3 16.3mm). In 9 cases (5.1%), ovarian endometriosis was
associated with rectovaginal nodules. The remaining 61 pa-
tients showed peritoneal lesions or adhesions or both In the
long-term follow-up examinations (mean time 6.9 4.1 years,
range 1–15 years), 134 (75.7%)womenwere followed formore
than 2 years (Fig. 1). Ninety of these women decided to un-
dergo ART treatment after surgery (study group), and 87
never underwent ART during the follow-up period (control
group). In the study group, 20 patients were submitted to both
IUI (1–6 cycles) and IVF (1–6 cycles). Thirty-six were treated
with IVF only and 34 with IUI only.
Patients’ characteristics in the study and control groups are
shown in Table 1.When comparing patients’ characteristics in
the ART and control (no ART) groups, the mean age, follow-
up period, and number of pregnancies were similar. In the
ART group, the duration of infertility was significantly longer
(4.7 3 years vs 2.8 1.9 years, respectively), and endome-
triosis was diagnosed at a more severe stage than in the no
ART group (control group). The proportion of infertile wo-
men with endometriosis who undergo ART was surprisingly
higher in stages I–II. These differences can be explained partly
by longer duration of infertility in this group. One hundred
seven (60.4%) patients were treated with 3–6 months of
GnRH-a immediately after the first laparoscopy, 61 (67.8%) in
the ART group and 46 (52.9%) controls ( p¼ 0.043). No further
medical treatments were proposed immediately after lap-
aroscopy, giving the couple an opportunity to seek spon-
taneous conception for a period of time. In the long-term
follow-up examinations, we observed a total of 40 (22.6%)
recurrences through TV-US. Eighteen (20%) were observed in
patients submitted to ART, and 22 (25.3%) were observed in
the control group. No differences were observed on the basis
of postoperative medical treatment, with 27 (25.2%) recur-
rences in 107 women treated with GnRH-a after surgery and
13 (18.6%) in 70 not receiving any medical treatment ( p¼ 0.3).
A second surgery was performed in 15 women (37.5%)
with TV-US recurrence. Two of these womenwere in the ART
group (2.2%), and 13 were in the control group (14.9%,
p¼ 0.002). In all our cases, surgery confirmed previous US
findings. Six patients experiencing recurrence (15%) followed
a medical treatment, whereas 19 (47.5%) did not receive any
treatment. The recurrent lesions observed were 19 ovarian
cysts (47.5%), 15 ovarian nodules (37.5%), and 6 deep recto-
vaginal endometriosis (15%). Small hypoechoic nodules were
observed mainly in women who underwent ART after lapa-
roscopy, whereas ovarian endometriomas were observed in
women in the control group. To specify, the recurrent lesions
were 10 small hypoechoic nodules in the ART group and 5 in
the control group, 5 ovarian endometriomas in theART group
FIG. 1. Number of patients involved in follow-up for every
year. Each bar represents the total number of women. The
black portions indicate the number of women with stages
III–IV, and the open portion shows the number of women
with stages I–II.
Table 1. Patient Characteristics of Women
in Study Group (Those Submitted to Assisted
Reproductive Technology After Surgery)
and in Control Group (Those Never Submitted)
Characteristic
ART postsurgery
(n¼ 90)
No ART
(n¼ 87) p
Mean age at
surgery, mean SD
33.7 4.3 33.2 5 0.502
Mean follow-up duration,
months, mean SD
68.9 41.8 73.2 53.3 0.549
Duration of infertility,
years (mean SD)
4.7 3 2.8 1.9 0.001
Stages I–II, n (%) 35 (38.9) 20 (23) 0.022
Stages III–IV, n (%) 55 (61.1) 67 (77)
Patients with pain, n (%) 50 (55.6) 60 (69) 0.066
Postlaparoscopy
GnRH-a, n (%)
61 (67.8) 46 (52.9) 0.043
Total pregnancies, n (%) 49 (55.1) 47 (54) 1
Spontaneous
pregnancies, n (%)
16 (17.8) 47 (54) 0.0001
ART pregnancies, n (%) 33 (36.7) -
ART, assisted reproductive technology; GnRH-a, gonadotropin-
releasing hormone; SD, standard deviation.
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and 14 in the control group, and 3 cases of deep rectovaginal
endometriosis in each group (Fig. 2).
Most recurrences were observed in the first 2 years after
surgery (22 recurrences, representing a rate of 55%). Figure 3
shows the distribution of recurrent lesions in relation to the
time after the first laparoscopy in the ART and control groups.
The overall cumulative recurrence rate was 35.2%; the cu-
mulative recurrence rates in the study and control groups
were 28.6% and 37.9%, respectively ( p¼ 0.471) (Fig. 4). The
mean time for recurrence was similar in both groups
(39.3 31.6 in the ART group and 38.8 43 in the control
group, p¼ 0.964). In addition, the type and number of cycles
performed did not show any significant association with the
risk of recurrences. The recurrence rate was 19.4% (7 of 36
recurrences) in the IVF-only group, 17.6% (6 of 34 recurrences)
in the IUI-only group, and 25% (5 of 20 recurrences) in the
IVF-IUI group. Women with recurrence underwent a number
of IUI and IVF cycles (2.5 0.7 IUI cycles and 1.8 1.3 IVF
cycles, respectively), comparable to that of women who did
not show recurrences (3.04 1.4 IUI cycles and 2.3 1.5 IVF
cycles, respectively ) ( p¼ 0.25 and p¼ 0.21).
When stratifying results considering the stage of endome-
triosis, recurrences were significantly higher in patients with
moderate to severe stages of the disease in both groups: 27.3%
(15 of 55 patients) in the ART group and 31.3% (21 of 67
patients) in the control group. The estimated mean delay for
recurrence was 37.9 39.4 months in stages III–IV and
51.5 15.3 in stages I–II ( p¼ 0.494).
One hundred ten women suffered from pelvic pain (chronic
pelvic pain, dysmenorrhea, or dyspareunia) at the time of the
first laparoscopy. Mean VAS as scored by patients before the
first surgery was chronic pelvic pain 7.7 1.2 (29 patients),
dysmenorrhea 8.4 1.3 (92 patients), and dyspareunia 7.6 1.2
(20 patients). The stratified analysis for pelvic pain at the time of
surgery did not show any differences. Furthermore, in both the
ART and control groups, themean time surgery recurrence was
shorter in women with pelvic pain in comparison to asymp-
tomatic patients (32.2 35.5 months vs. 56.9 39.5 months, re-
spectively, p¼ 0.065). Table 2 shows the results of this analysis.
FIG. 2. Recurrent lesions observed during follow-up ex-
aminations. Each bar represents the total number of recur-
rent lesions (cyst, nodule, or deep endometriosis). Bars are
stacked on the basis of study=control group. ART, assisted
reproductive technology.
FIG. 3. Recurrent lesions observed in the study and control groups. The stacked bars show the number of patients having
recurrences during follow-up examinations (2-year interval). In each column, recurrent lesions (cyst, nodule, deep endometri-
osis) are shown.
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Discussion
Endometriosis is a chronic disease, and recurrence rates
after the first surgery are estimated to range from approxi-
mately 2% to 51%.3,4 This wide rangemay, in part, be ascribed
to different criteria for the definition of recurrence, a lack of
long-term follow-up studies, and a lack of homogeneous
groups. Most of the published studies to date have focused on
recurrence rates after short or intermediate periods. Only a
few studies have provided long-term follow-up data. In a
prospective cohort multicenter study, the 2-year recurrence
rate was 5.7% among stage I–II patients and 14.4% among
stage III–IV patients ( p< 0.05).3
The benefits of surgical therapy for endometriosis-related
infertility have been well documented.1,18,19 With the large
diffusion of ART, however a growing number of infertile
women with a history of endometriosis attempt this treat-
ment. In a previous study, after an integrated laparoscopy-
IVF approach, we obtained a pregnancy rate of 56.1%, which
is significantly higher than the 37.4% observed after surgery
only.20 During COH for ART, the risks of recurrence or
worsening of endometriosis could be higher because of the
elevated E2 levels induced. On the other hand, this assump-
tion could be simplistic, as we have acknowledged that es-
trogen and progesterone receptors have different expressions
in eutopic and ectopic endometrium.21
Although several articles about endometriosis have been
published in recent years, long-term data about recurrence
risk rates in infertile women subsequent to ART are scarce. To
determine if COH for ART might be associated with an in-
creased incidence of endometriosis recurrence, we compared
two homogeneous groups of women with infertility-related
endometriosis: 90 women submitted to COH for ART after
surgery (study group) and 87 women never undergoing COH
(control group). In the literature, there is still no standardized
definition of endometriosis recurrence. Some authors have
considered recurrence of pain (dysmenorrhea, dyspareunia,
chronic pelvic pain), US findings, or increased CA125 levels.
This fact makes it difficult to compare results among previous
studies about endometriosis recurrence. We decided to ex-
amine our findings through TV-US, which is generally con-
sidered the most objective, noninvasive, reproducible, and
cost-effective method. Many studies have validated the non-
surgical diagnosis of endometriomas and deep endometriosis
through TV-US.10–17 Some authors observed a sensitivity of
81%–89% and a specificity of 91%–97% in predicting the en-
dometriotic nature of ovarian cysts.22 Regarding deep endo-
metriosis, Guerriero et al.17 observed a high specificity and
sensitivity in the detection of vaginal wall lesions (sensitivity
of 91%, specificity of 89%) and rectovaginal endometriosis
(sensitivity of 74%, specificity of 88%). For other locations, the
sensitivity was lower (ranging from 67% to 33%) with a
comparable specificity. We observed a total of 40 (22.6%) re-
currences by TV-US, 18 (20%) in patients submitted to ART
and 22 (25.3%) in the control group. Survival curves showed a
cumulative recurrence rate of 28.6% in patients submitted to
ART, which was similar to the 37.9% observed in the control
group ( p¼ 0.471).
Previous studies have shown that recurrence rates of en-
dometriosis tend to be lower in women with infertility and
higher inwomenwith advanced stages of the disease or pelvic
pain.3,23 Our study confirmed these conclusions. Patients with
severe stages of the disease were more likely to have a re-
currence in both the ART and control groups. Furthermore,
patients with pelvic pain at the time of their first surgery for
endometriosis seemed more likely to develop recurrence in a
shorter time span. However, no differences were found be-
tween the two groups based on the stage of endometriosis and
the presence of pelvic pain before surgery.
Of the 177 patients included in the study, 15 (19.5%) were
submitted to a second surgery during the follow-up period.
Two of these patients were from the ART group and 13 were
FIG. 4. Kaplan-Meier analysis of the effect of ovarian hyper-
stimulation on recurrence of endometriosis. Cumulative re-
currence rates in the study and control groups were not
statistically significant ( p¼ 0.471, two-sided log-rank test).
Vertical tick marks represent censored patients.
Table 2. Recurrences Stratified on Basis of Pelvic Pain and Stages
ART postsurgery Control group
Patients Recurrences Patients Recurrences
n n % p n n % p
90 18 20 - 87 22 25.3 -
Stages I–II 35 3 8.6 0.031 Stages I–II 20 1 5 0.017
Stages III–IV 55 15 27.3 Stages III–IV 67 21 31.3
Pelvic pain 50 13 26 0.185 Pelvic pain 60 16 26.7 0.861
No pelvic pain 40 5 12.5 No pelvic pain 27 6 22.2
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from the control group. In a recent study evaluating re-
operation rates over a 10-year period, 51% of patients un-
derwent an additional operation after the initial surgery.4 In
the present study, there was a noticeable reduction of re-
operation rates. This could be explained by the fact that
our study selected women with subfertility problems who
subsequently achieved pregnancy. As we acknowledge, preg-
nancy could have a protective effect on endometriosis recur-
rence. In addition, women with infertility are less likely to be
reoperated on compared with women whose principal
symptom is pelvic pain. The rationale is partly because there
are still doubts about the effect of repeated surgery on the
outcome of subsequent IVF treatments.
Our study is partially limited by the self-selected group
choosing to have ART treatment after laparoscopy because
the decision is related to personal and ethical issues where
physicians cannot interfere. Furthermore, we acknowledge
that we might have missed the presence of minimal recurrent
lesions not diagnosed by TV, and because of the long term
follow-up period, our patients were observed using US ma-
chines of progressively improved resolution and for different
durations of observation. To minimize the potential diag-
nostic mistakes, we included patients in the study who un-
derwent TV-US at least once a year after the first laparoscopy.
Indeed, minimal recurrent lesions not visualized at the be-
ginning could be diagnosed in the later scans. In addition,
Kaplan-Meyer analysis allowed us an estimation of recur-
rence risk over time even when patients dropped out or were
studied for different lengths of time. Consequently, each pa-
tient contributed to the survival curve for the entire length of
time she was followed but was statistically removed from the
curve after that time.
Considering these points, we finally conclude that GnRH
treatments causing high E2 blood levels for brief periods do
not appear to affect the natural history of endometriosis. Al-
though endometriosis is typically an estrogen-dependent
disease and can frequently recur, we obtained similar recur-
rence rates in patients submitted to ART and those in the
control group. Therefore, the results of our study may be
encouraging for patients with infertility-related endometri-
osis who decide to attempt ART after surgery. The most im-
portant prognostic factors for this recurrent disease seem to be
the stage of endometriosis and the degree of pain at the time of
first laparoscopic treatment.
To the best of our knowledge, this study represents one of
the first large-scale studies that provides long-term results of
cumulative recurrence rates using TV-US in women with in-
fertility-related endometriosis. Further trials, with larger
samples and long-term follow-up, might possibly give addi-
tional strength to our findings. In the literature, there is almost
no information on clinical trials estimating recurrence risks in
infertile women with endometriosis treated with ART, prob-
ably because of the difficulty of designing such a study.
However, the information provided by this research field is
essential in order to offer the best counseling to infertile pa-
tients with endometriosis.
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